Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.-Reference-Cited by-同舟云学术

Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.

Published:1993-04 Issue:4 Volume:35 Page:379-385
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Weller C,O'Neill CJ,Charlett A,Bowes SG,Purkiss A,Nicholson PW,Dobbs RJ,Dobbs SM

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1993.tb04154.x/fullpdf

Reference25 articles.

1. Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbodopa;Bowes;Eur. J. clin. Pharmac.,1992a

2. Gait in relation to ageing and idiopathic Parkinsonism;Bowes;Scand. J. Rehab. Med.,1992b

3. Objective outcome criteria in trials of anti-Parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia;Bowes;Br. J. clin. Pharmac.,1991

4. A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100);Cederbaum;Neurology,1989

5. Bioavailability of L-Dopa after Madopar HBS administration in healthy volunteers;Crevoisier;Eur. Neurol.,1987

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson’s disease motor symptoms;npj Digital Medicine;2022-03-18

2. Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism;Journal of Clinical Medicine;2020-07-08

3. A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders;Advanced Drug Delivery Reviews;2019-08

4. Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson’s disease;Journal of Neural Transmission;2017-10-10

5. Partial Body Weight-Supported Treadmill Training in Patients With Parkinson Disease: Impact on Gait and Clinical Manifestation;Archives of Physical Medicine and Rehabilitation;2015-09